glp 1 compounding update FDA says that the GLP-1 shortage is over Compounded GLP-1s are entering a

It alleges that Novo Nordisk failed to adequately warn consumers and healthcare providers about the risk of severe vision injuries associated with semaglutide-based medications

Last Published 02.01.2026 Effective Date: 02.01.2026 This policy addresses breast imaging, including digital mammography, magnetic resonance imaging (MRI), ultrasound, automated breast ultrasound system, computer-aided detection (CAD), computer-aided tactile breast imaging, electrical impedance scanning (EIS), magnetic resonance elastography (MRE), and molecular breast imaging

Nine patients with anti-SLA had a diagnosis of primary sclerosing cholangitis, 7 of whom were thought to have a component of AIH and treated with immunosuppression

Semaglutide delays 4-hour gastric emptying in women with polycystic ovary syndrome and obesity